As Vice President of Research Operations, Mr. Hellerstein leads the group responsible for process and analytical development, preclinical research management, and bioanalysis. Initially trained as a molecular biologist, Mr. Hellerstein began his career in pharmaceutical research laboratories and then expanded into vaccine and biologics discovery and development, quality control and assurance, regulatory affairs, outsourcing, project management, and contracting. With experience in a wide range of functional areas, Mr. Hellerstein brings a great breadth of expertise in biotech and biopharmaceutical development. Prior to joining Vaxxinity, Mr. Hellerstein held positions at Kiel Laboratories, GeoVax, Pfizer, Cell Signaling Technology, and Blue Sky Biotech. He also founded and provided services through his regulatory affairs and quality consulting firm, Hellerstein Consulting.